PMC:7600245 / 37411-37609
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T337 | 9-10 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T338 | 54-57 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T339 | 182-186 | http://purl.obolibrary.org/obo/CLO_0001360 | denotes | 4–12 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T572 | 84-93 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T277 | 0-198 | Sentence | denotes | In fact, a recent clinical study results under review has indicated that danoprevir/ritonavir combination alleviated the symptoms in COVID-patients and accelerated their recovery in 4–12 days [115]. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1109 | 139-147 | Species | denotes | patients | Tax:9606 |
| 1117 | 73-83 | Chemical | denotes | danoprevir | MESH:C553752 |
| 1118 | 84-93 | Chemical | denotes | ritonavir | MESH:D019438 |
| 1121 | 133-138 | Disease | denotes | COVID | MESH:C000657245 |